Incyte Corp (INCY) stock
INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$117.80−1.29 (-1.08%)
Close on Nov 18, 2026Market cap $24.01BP/E 62.7Yield –
Incyte price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Incyte's price to book ratio was 3.9× on Nov 11, 2026, against 4.4× a year earlier. Over the last 5 years it ranged from 2.2× to 5.2×, with a median of 3.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.9× | −0.3 |
| 2025 | Dec 31, 2025 | 4.2× | −0.0 |
| 2024 | Dec 31, 2024 | 4.2× | +1.3 |
| 2023 | Dec 29, 2023 | 2.9× | −1.4 |
| 2022 | Dec 30, 2022 | 4.2× | −0.9 |
| 2021 | Dec 31, 2021 | 5.1× | −2.8 |
| 2020 | Dec 31, 2020 | 8.0× | +0.2 |
| 2019 | Dec 31, 2019 | 7.8× | +0.3 |
| 2018 | Dec 31, 2018 | 7.5× | −3.9 |
| 2017 | Dec 29, 2017 | 11.4× | −39.7 |
| 2016 | Dec 30, 2016 | 51.0× | −176.3 |
| 2015 | Dec 31, 2015 | 227.3× | −138.8 |
| 2014 | Jan 31, 2014 | 366.1× | +83.2 |
| 2013 | Dec 31, 2013 | 282.9× | – |
See a number that looks wrong?